David J. Grainger

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cheshire, United Kingdom
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Gregory Weinhoff, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David J. Grainger

Form 4 holding Chief Innovation Officer

Centessa Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
962,790
Estimated value
$7,663,808
Report date
31 Dec 2023
Price
$7.96
Ownership
Direct
Form 4 holding Chief Innovation Officer

Centessa Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
27,500
Estimated value
$218,900
Report date
31 Dec 2023
Price
$7.96
Ownership
Indirect

Insider Reports Filed by David J. Grainger

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .